USP22 and cancer: As being summarized in Fig. 8, this study is the first to report that targeting USP7 either by siRNA-mediated knockdown or pharmacological inhibition induces a dramatic transcriptional upregulation of USP22, an important Dub in most cancers and a potential target for cancer treatment.